Chronic Thromboembolic Disease and Chronic Thromboembolic Pulmonary Hypertension

descriptionPublicationkeyboard_double_arrow_right Article 01 Mar 2021 English Publisher:Elsevier BVJournal:Clinics in Chest Medicine, volume 42, pages 81-90 (issn: 0272-5231,

Copyright policy )

Authors: Irene M, Lang; Ioana A, Campean; Roela, Sadushi-Kolici; Roza, Badr-Eslam; Christian, Gerges; Nika, Skoro-Sajer;

doi: 10.1016/j.ccm.2020.11.014

pmid: 33541619

Chronic Thromboembolic Disease and Chronic Thromboembolic Pulmonary Hypertension

- Summary
- Subjects
- Metrics

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) and chronic thromboembolic pulmonary vascular disease (CTED) are rare manifestations of venous thromboembolism. Presumably, CTEPH and CTED are variants of the same pathophysiological mechanism. CTEPH and CTED can be near-cured by pulmonary endarterectomy, balloon pulmonary angioplasty, and medical treatment with Riociguat or subcutaneous treprostinil, which are the approved drugs.

Related Organizations

Medical University of Vienna
Austria

Keywords

Hypertension, Pulmonary, Chronic Disease, Humans, Venous Thromboembolism, Pulmonary Embolism

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	32
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%